Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Julphar
UBS
McKinsey
Mallinckrodt
McKesson
Dow
Cantor Fitzgerald
Johnson and Johnson
AstraZeneca

Generated: February 23, 2018

DrugPatentWatch Database Preview

Pharm Res Assoc Company Profile

« Back to Dashboard

What is the competitive landscape for PHARM RES ASSOC, and what generic and branded alternatives to PHARM RES ASSOC drugs are available?

PHARM RES ASSOC has eight approved drugs.



Summary for Pharm Res Assoc
US Patents:0
Tradenames:9
Ingredients:9
NDAs:8

Drugs and US Patents for Pharm Res Assoc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharm Res Assoc PHYLLOCONTIN aminophylline TABLET, EXTENDED RELEASE;ORAL 086760-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Pharm Res Assoc CERUMENEX trolamine polypeptide oleate condensate SOLUTION/DROPS;OTIC 011340-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Pharm Res Assoc ATHROMBIN warfarin sodium TABLET;ORAL 011771-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Pharm Res Assoc DHC PLUS acetaminophen; caffeine; dihydrocodeine bitartrate CAPSULE;ORAL 088584-001 Mar 4, 1986 DISCN No No ➤ Sign Up ➤ Sign Up
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Pharm Res Assoc PHENY-PAS-TEBAMIN phenyl aminosalicylate TABLET;ORAL 011695-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Pharm Res Assoc CARDIOQUIN quinidine polygalacturonate TABLET;ORAL 011642-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Pharm Res Assoc SULFABID sulfaphenazole SUSPENSION;ORAL 013093-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Express Scripts
Mallinckrodt
Accenture
Citi
Harvard Business School
Federal Trade Commission
Argus Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot